Sebastian Schuchmann, a neuroscience researcher whose duplication errors led to a Cell correction last year, has retracted a 12-year-old paper in the Journal of Neurochemistry whose figures were copied from two of his earlier papers.
Here’s the notice: Continue reading Author whose duplications forced Cell correction retracts paper on Down syndrome
The social psychology community, already rocked last year by the Diederik Stapel scandal, now has another set of allegations to dissect. Dirk Smeesters, a professor of consumer behavior and society at the Rotterdam School of Management, part of Erasmus University, has resigned amid serious questions about his work.
According to an Erasmus press release, a scientific integrity committee found that the results in two of Smeesters’ papers were statistically highly unlikely. Smeesters could not produce the raw data behind the findings, and told the committee that he cherry-picked the data to produce a statistically significant result. Those two papers are being retracted, and the university accepted Smeesters’ resignation on June 21.
The release also takes pains to say that the university has no reason to doubt the work of his co-authors. You can read the complete report in Dutch, with Smeesters’ co-authors’ names blacked out, in an NRC Handelsblad story.
Erasmus tells Retraction Watch that these are the two papers being retracted: Continue reading Following investigation, Erasmus social psychology professor retracts two studies, resigns
Edward Shang, the weight loss surgeon who lost his job at the University of Leipzig in May after it was revealed that he had made up most, if not all, of the patients in his research studies at the University of Mannheim, has retracted three more papers.
Here’s the notice, which is a bit, um, lean, given what we know about the case: Continue reading Three more retractions for weight loss surgeon Edward Shang for making up data
Philosophical Transactions of the Royal Society A is retracting a 2010 paper whose authors misappropriated data, forged an author name — and got a pretty strong backhand slap for the trouble.
The paper, “Green waxes, adhesives and lubricants,” which refers to eco-friendly materials, not Halloween-friendly slimes, was published by a group of researchers from China and Canada. Problem was, the one from Canada evidently didn’t know she was listed on the manuscript, and a big chunk of the work had been misappropriated from her university.
As the notice explains: Continue reading Misconduct burns authors of wax paper, leads to sharply worded retraction notice
With temperatures at Retraction Watch’s New York HQ threatening to break 100 degrees today — that’s nearly 38 degrees Celsius for those of you in the rest of the world — what better way to take our minds off the heat than by writing about than skiing?
Lucky for us, the author of a paper in the Journal of Maps about new ways to create ski resort maps — aka the “Breckenridge schematic map” — has retracted it. Here’s the notice: Continue reading Updated: Ski resort paper hits a (media) mogul and gets retracted
Are drug company R&D departments reading blogs?
In a recent paper, “Translational evaluation of JNJ-18038683, a 5-HT7 receptor antagonist, on REM sleep and in major depressive disorder,” researchers with New Jersey-based Janssen Pharmaceuticals Inc. tested whether a potential drug code-named JNJ-18038683 that binds to a receptor linked to depression could actually help patients.
Turns out, the drug was a flop, but Continue reading JPET corrects Janssen antidepressant paper after neuroscience blogger notes errors
A group of researchers at the drug company ChemoCentryx is withdrawing a 2012 paper in the Journal of Pharmacology and Experimental Therapeutics over failure to appropriately identify the molecule they describe in the article.
The withdrawal notice tells the story: Continue reading JPET peeves: Paper withdrawn after drug company won’t disclose chemical structure
Last August, we brought you the news that the Indian Journal of Dermatology had banned a group of Tunisian researchers from publishing in the journal for five years, because they had plagiarized in a 2009 study.
Well, the journal’s editors found another case in which the authors have plagiarized, and now they’re banned from the journal for good. Here’s the notice, which describes both cases: Continue reading Serial plagiarizers banned from dermatology journal forever
Three journals under the JAMA umbrella are retracting papers by Yoshitaka Fujii, the Japanese anesthesiologist accused of research misconduct so sweeping that it might net him the record for most retractions by a single author.
The papers, in the Archives of Surgery, Archives of Ophthalmology and the Archives of Otolaryngology — Head & Neck Surgery, were published in 2001 and 2005.
Here are the notices, which are essentially identical but for the titles of the articles: Continue reading Three more Fujii papers fall for lack of IRB approval
PLoS ONE has issued an expression of concern over a 2010 paper by Chinese scientists about how the immune system responds to the vaccine against the swine flu.
The article, “Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine,” claimed to study 58 subjects given the inoculation (more on that below) and that Continue reading PLoS ONE expresses concern over flu vaccine paper